Authors:
Isik, R
Metintas, M
Gibbs, AR
Metintas, S
Jasani, B
Oner, U
Harmanci, E
Demircan, S
Isiksoy, S
Citation: R. Isik et al., p53, p21 and metallothionein immunoreactivities in patients with malignantpleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure, RESP MED, 95(7), 2001, pp. 588-593
Authors:
Metintas, M
Metintas, S
Ucgun, I
Gibbs, AR
Harmanci, E
Alatas, F
Erginel, S
Tel, N
Pasaoglu, O
Citation: M. Metintas et al., Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics, RESP MED, 95(10), 2001, pp. 829-835
Authors:
Alatas, F
Alatas, O
Metintas, M
Colak, O
Harmanci, E
Demir, S
Citation: F. Alatas et al., Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions, LUNG CANC, 31(1), 2001, pp. 9-16
Authors:
Harmanci, E
Metintas, M
Alatas, F
Erginel, S
Mutlu, S
Citation: E. Harmanci et al., Low prevalence of allergy to cockroach and latex in asthmatic patients in Eskisehir (Anatolia), Turkey, J INVES ALL, 10(3), 2000, pp. 162-165
Citation: M. Metintas et al., Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort, EUR RESP J, 13(3), 1999, pp. 523-526
Authors:
Metintas, M
Ozdemir, N
Ucgun, I
Elbek, O
Kolsuz, M
Mutlu, S
Metintas, S
Citation: M. Metintas et al., Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma, CHEST, 116(2), 1999, pp. 391-398
Authors:
Ucgun, I
Ozdemir, N
Metintas, M
Metintas, S
Erginel, S
Kolsuz, M
Citation: I. Ucgun et al., Prevalence of occupational asthma among automobile and furniture painters in the center of Eskisehir (Turkey): the effects of atopy and smoking habits on occupational asthma, ALLERGY, 53(11), 1998, pp. 1096-1100